ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Oncolytics Biotech Inc

Oncolytics Biotech Inc (ONCY)

0,831
-0,0564
(-6,36%)
Geschlossen 22 Dezember 10:00PM
0,8297
-0,0013
(-0,16%)
Nach Börsenschluss: 12:56AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,8297
Gebot
0,8103
Fragen
0,92
Volumen
541.089
0,790001 Tagesbereich 0,89
0,7101 52-Wochen-Bereich 1,53
Marktkapitalisierung
Handelsende
0,8874
Handelsbeginn
0,86
Letzte Trade
1
@
0.83
Letzter Handelszeitpunkt
Finanzvolumen
US$ 459.998
VWAP
0,850135
Durchschnittliches Volumen (3 Mio.)
554.965
Ausgegebene Aktien
76.986.033
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,33
Gewinn pro Aktie (EPS)
-0,36
Erlöse
-
Nettogewinn
-27,75M

Über Oncolytics Biotech Inc

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as qui... Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Calgary, Alberta, Can
Gegründet
-
Oncolytics Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ONCY. The last closing price for Oncolytics Biotech was US$0,89. Over the last year, Oncolytics Biotech shares have traded in a share price range of US$ 0,7101 to US$ 1,53.

Oncolytics Biotech currently has 76.986.033 shares in issue. The market capitalisation of Oncolytics Biotech is US$68,32 million. Oncolytics Biotech has a price to earnings ratio (PE ratio) of -2.33.

ONCY Neueste Nachrichten

Sernova Corp. Announces Appointment of New Chief Executive Officer

LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0054-0.646629146210.83510.9299990.71016936960.81378602CS
4-0.1504-15.34537292110.98010.99990.71014270430.86150247CS
12-0.0703-7.811111111110.91.530.71015549651.11514446CS
26-0.2103-20.22115384621.041.530.71013521421.07970329CS
52-0.4703-36.17692307691.31.530.71013415371.09789434CS
156-0.6503-43.93918918921.483.39420.71013566471.71179985CS
260-0.7903-48.78395061731.626.020.71015777252.43750043CS

ONCY - Frequently Asked Questions (FAQ)

What is the current Oncolytics Biotech share price?
The current share price of Oncolytics Biotech is US$ 0,8297
How many Oncolytics Biotech shares are in issue?
Oncolytics Biotech has 76.986.033 shares in issue
What is the market cap of Oncolytics Biotech?
The market capitalisation of Oncolytics Biotech is USD 68,32M
What is the 1 year trading range for Oncolytics Biotech share price?
Oncolytics Biotech has traded in the range of US$ 0,7101 to US$ 1,53 during the past year
What is the PE ratio of Oncolytics Biotech?
The price to earnings ratio of Oncolytics Biotech is -2,33
What is the reporting currency for Oncolytics Biotech?
Oncolytics Biotech reports financial results in CAD
What is the latest annual profit for Oncolytics Biotech?
The latest annual profit of Oncolytics Biotech is CAD -27,75M
What is the registered address of Oncolytics Biotech?
The registered address for Oncolytics Biotech is 1167 KENSINGTON CRESCENT NW, SUITE 210, CALGARY, ALBERTA, T2N 1X7
What is the Oncolytics Biotech website address?
The website address for Oncolytics Biotech is www.oncolyticsbiotech.com
Which industry sector does Oncolytics Biotech operate in?
Oncolytics Biotech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock